Board has recommended final dividend for the Financial Year 2025-26, subject to approval of shareholders.
PGHL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Procter & Gamble Health Ltd reported strong FY 2025-26 results with net profit of Rs. 32,691 lakhs, up 39% from Rs. 23,441 lakhs in the prior 9-month period. Revenue from operations grew to Rs. 140,797 lakhs from Rs. 93,417 lakhs. The Board recommended a final dividend of Rs. 45 per share (face value Rs. 10), aggregating Rs. 7,470 lakhs, subject to shareholder approval at the 59th AGM. Total dividend for FY 2025-26 amounts to Rs. 205 per share, combining the earlier interim dividend of Rs. 160 and a one-time special dividend. EPS for the year stood at Rs. 196.94. Note: The company changed its financial year-end from June 30 to March 31, making prior period comparisons only indicative.
The company delivered robust profit growth with a total dividend of Rs. 205 per share, signaling strong cash generation and shareholder-friendly policy. The final dividend is subject to AGM approval and will be paid on or before September 25, 2026.